Abstract
Purpose
Hearing loss is a frequently observed comorbidity in patients with nasopharyngeal carcinoma (NPC). Accumulating evidence demonstrated that acupuncture can safely manage cancer and its treatment-related symptoms, but its effect in minimizing the likelihood of experiencing sudden sensorineural hearing loss (SSHL) has not been established. So this work aimed to determine the risk of SSHL among NPC persons with or without acupuncture use.
Methods
One population-level, nested case–control design within a cohort study is employed. Relevant information on persons aged 20–80 years who were afflicted with NPC between 2000 and 2010 was extracted from a nationwide health claims database. From them, we identified the cases who had the first SSHL diagnosis occurring after NPC, and all of them were randomly matched to two controls without SSHL. Conditional logistic regression was employed to calculate odds ratios (OR) and its respective 95% confidence intervals (CI) for incident SSHL in relation to acupuncture treatment.
Results
Eight hundred eleven SSHL cases were randomly matched to 1452 controls. Those receiving conventional care plus acupuncture use had a reduced adjusted OR of 0.39 (95% CI, 0.25–0.60) for SSHL. We further discovered that the longer usage of acupuncture remarkably correlated with reduction of SSHL risk in a dose-dependent manner.
Conclusions
Delineation of the benefit from integration of acupuncture into conventional care may be a reference in instituting more appropriate care for NPC subjects.
Implications for Cancer Survivors
Patients living with NPC may benefit from a timely integration of acupuncture into routine care to lessen SSHL risk.
Graphical Abstract
Similar content being viewed by others
Data availability
The data that support the findings of this study are available from Taiwan’s NHI Administration, which administers the NHIRD, but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are, however, available from Taiwan’s NHI Administration (https://eng.nhi.gov.tw/en/mp-2.html).
Abbreviations
- BDNF:
-
Brain-derived neurotrophic factor
- CCI:
-
Charlson–Deyo Comorbidity Index
- CCRT:
-
Concomitant chemotherapy and radiotherapy
- CI:
-
Confidence interval
- CIR:
-
Catastrophic Illness Registry
- ICD-9-CM:
-
International Classification of Diseases, Ninth Revision, Clinical Modification
- IL-6:
-
Interleukin-6
- NF-êB:
-
Nuclear factor kappa-light-chain-enhancer of activated B cells
- NHI:
-
National Health Insurance
- NHIRD:
-
National Health Insurance Research Database
- NPC:
-
Nasopharyngeal carcinoma
- OR:
-
Odds ratio
- PI3K:
-
Phosphatidylinositol 3-kinase
- RT:
-
Radiotherapy
- SD:
-
Standard deviation
- SSHL:
-
Sudden sensorineural hearing loss
- TCM:
-
Traditional Chinese medicine
- TNF-á:
-
Tumor necrosis factor-alpha
References
Bossi P, Chan AT, Licitra L, Trama A, Orlandi E, Hui EP, et al. Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up(dagger). Ann Oncol. 2021;32(4):452–65.
Chua MLK, Wee JTS, Hui EP, Chan ATC. Nasopharyngeal carcinoma. Lancet. 2016;387(10022):1012–24.
Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol. 1998;16(4):1310–7.
Prasad U, Pua KC. Nasopharyngeal carcinoma: a delay in diagnosis. Med J Malays. 2000;55(2):230–5.
Skinner DW, Van Hasselt CA, Tsao SY. Nasopharyngeal carcinoma: modes of presentation. Ann Otol Rhinol Laryngol. 1991;100(7):544–51.
Kuhn M, Heman-Ackah SE, Shaikh JA, Roehm PC. Sudden sensorineural hearing loss: a review of diagnosis, treatment, and prognosis. Trends Amplif. 2011;15(3):91–105.
Tian YM, Guan Y, **ao WW, Zeng L, Liu S, Lu TX, et al. Long-term survival and late complications in intensity-modulated radiotherapy of locally recurrent T1 to T2 nasopharyngeal carcinoma. Head Neck. 2016;38(2):225–31.
Al-Kholy AF, Abdullah OA, Abadier MZ, Hassaan MM, Shindy MF, Nor El-Dien DM, et al. Pre-treatment serum inflammatory cytokines as survival predictors of patients with nasopharyngeal carcinoma receiving chemoradiotherapy. Mol Clin Oncol. 2016;5(6):811–6.
Hazlitt RA, Min J, Zuo J. Progress in the development of preventative drugs for cisplatin-induced hearing loss. J Med Chem. 2018;61(13):5512–24.
Rybak LP, Mukherjea D, Ramkumar V. Mechanisms of cisplatin-induced ototoxicity and prevention. Semin Hear. 2019;40(2):197–204.
Wei Y, Zhou T, Zhu J, Zhang Y, Sun M, Ding X, et al. Long-term outcome of sensorineural hearing loss in nasopharyngeal carcinoma patients: comparison between treatment with radiotherapy alone and chemoradiotherapy. Cell Biochem Biophys. 2014;69(3):433–7.
Samaha NL, Almasri MM, Johns JD, Hoa M. Hearing restoration and the stria vascularis: evidence for the role of the immune system in hearing restoration. Curr Opin Otolaryngol Head Neck Surg. 2021;29(5):373–84.
Raaijmakers E, Engelen AM. Is sensorineural hearing loss a possible side effect of nasopharyngeal and parotid irradiation? A systematic review of the literature. Radiother Oncol. 2002;65(1):1–7.
Petsuksiri J, Sermsree A, Thephamongkhol K, Keskool P, Thongyai K, Chansilpa Y, et al. Sensorineural hearing loss after concurrent chemoradiotherapy in nasopharyngeal cancer patients. Radiat Oncol. 2011;6:19.
Kim SY, Min C, Kim HJ, Lee CH, Sim S, Park B, et al. Mortality and cause of death in hearing loss participants: a longitudinal follow-up study using a national sample cohort. Otol Neurotol. 2020;41(1):25–32.
Yin CS, Park HJ, Nam HJ. Acupuncture for refractory cases of sudden sensorineural hearing loss. J Altern Complement Med. 2010;16(9):973–8.
Chen S, Zhao M, Qiu J. Acupuncture for the treatment of sudden sensorineural hearing loss: a systematic review and meta-analysis: acupuncture for SSNHL. Complement Ther Med. 2019;42:381–8.
Liu P, Yu X, Dai X, Zou W, Yu X, Niu M, et al. Scalp acupuncture attenuates brain damage after intracerebral hemorrhage through enhanced mitophagy and reduced apoptosis in rats. Front Aging Neurosci. 2021;13: 718631.
Liu F, Han X, Li Y, Yu S. Acupuncture in the treatment of tinnitus: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol. 2016;273(2):285–94.
National Health Insurance Administration. National Health Insurance Database. Available online: https://nhird.nhri.edu.tw//en/index.html.
Koo M, Hwang JH. Risk of sudden sensorineural hearing loss in patients with common preexisting sensorineural hearing impairment: a population-based study in Taiwan. PLoS ONE. 2015;10(3):e0121190.
Wu MY, Huang MC, Liao HH, Chiang JH, Lee YC, Hsu CY, et al. Acupuncture decreased the risk of coronary heart disease in patients with rheumatoid arthritis in Taiwan: a Nationwide propensity score-matched study. BMC Complement Altern Med. 2018;18(1):341.
Weng SW, Liao CC, Yeh CC, Chen TL, Lane HL, Lin JG, et al. Risk of epilepsy in stroke patients receiving acupuncture treatment: a nationwide retrospective matched-cohort study. BMJ Open. 2016;6(7):e010539.
Liu CY, Hung YT, Chuang YL, Chen YJ, Weng WS, Liu JS, et al. Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. J Health Manag. 2006;4(1):1–22.
Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–9.
Juan YH, Livneh H, Huang HJ, Lu MC, Yeh CC, Tsai TY. Decreased risk of dementia among patients with traumatic brain injury receiving acupuncture treatment: a population-based retrospective cohort study. J Head Trauma Rehabil. 2019;34(5):E17-23.
Breglio AM, Rusheen AE, Shide ED, Fernandez KA, Spielbauer KK, McLachlin KM, et al. Cisplatin is retained in the cochlea indefinitely following chemotherapy. Nat Commun. 2017;8(1):1654.
Wu J, Ye J, Kong W, Zhang S, Zheng Y. Programmed cell death pathways in hearing loss: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif. 2020;53(11):e12915.
Zhang Y, Lan R, Wang J, Li XY, Zhu DN, Ma YZ, et al. Acupuncture reduced apoptosis and up-regulated BDNF and GDNF expression in hippocampus following hypoxia-ischemia in neonatal rats. J Ethnopharmacol. 2015;172:124–32.
Xue X, You Y, Tao J, Ye X, Huang J, Yang S, et al. Electro-acupuncture at points of Zusanli and Quchi exerts anti-apoptotic effect through the modulation of PI3K/Akt signaling pathway. Neurosci Lett. 2014;558:14–9.
Dou SH, Cui Y, Huang SM, Zhang B. The role of brain-derived neurotrophic factor signaling in central nervous system disease pathogenesis. Front Hum Neurosci. 2022;16:924155.
Chen A, Lin Z, Lan L, **e G, Huang J, Lin J, et al. Electroacupuncture at the Quchi and Zusanli acupoints exerts neuroprotective role in cerebral ischemia-reperfusion injured rats via activation of the PI3K/Akt pathway. Int J Mol Med. 2012;30(4):791–6.
Chen J, Yuan H, Talaska AE, Hill K, Sha SH. Increased sensitivity to noise-induced hearing loss by blockade of endogenous PI3K/Akt signaling. J Assoc Res Otolaryngol. 2015;16(3):347–56.
Han RX, Yang J, Zhang TS, Zhang WD. Effect of fire-needle intervention on serum IL-1 and TNF-alpha levels of rheumatoid arthritis rats. Zhen Ci Yan Jiu. 2012;37(2):114–8.
Shih CC, Liao CC, Su YC, Tsai CC, Lin JG. Gender differences in traditional Chinese medicine use among adults in Taiwan. PLoS ONE. 2012;7(4):e32540.
Aljefree NM, Almoraie NM, Althaiban MA, Hanbazaza MA, Wazzan HA, Shatwan IM. Gender differences in knowledge, attitudes, and practices with respect to type 1 diabetes among Saudi public-school teachers. BMC Public Health. 2023;23(1):118.
Au A, Feher A, McPhee L, Jessa A, Oh S, Einstein G. Estrogens, inflammation and cognition. Front Neuroendocrinol. 2016;40:87–100.
Sunday L, Tran MM, Krause DN, Duckles SP. Estrogen and progestagens differentially modulate vascular proinflammatory factors. Am J Physiol Endocrinol Metab. 2006;291(2):E261–7.
Acknowledgements
This study uses data from the National Health Insurance Research Database provided by the Bureau of National Health Insurance, Department of Health, and managed by the National Health Research Institutes, Taiwan.
Author information
Authors and Affiliations
Contributions
Shen YJ, Liao HH, Lin MC and Tsai TY were involved in the study design and drafted the manuscript. Livneh H and Tsai TY contributed to data analysis and revised the manuscript. Livneh H, Lin MC and Li SC contributed to the interpretation of data and provided comments on the final draft of the manuscript. Lu MC and Liao HH provided administrative support and comments on the manuscript drafts. All authors gave final approval of the version to be published, and agree to be accountable for all aspects of the work.
Corresponding authors
Ethics declarations
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Disclaimer
The interpretation and conclusions contained herein do not represent those of the Bureau of National Health Insurance, Department of Health, or the National Health Research Institutes.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Shen, YJ., Liao, HH., Livneh, H. et al. Complementary acupuncture treatment and reduced risk of sudden sensorineural hearing loss in nasopharyngeal carcinoma patients: a retrospective, nested case–control study. J Cancer Surviv (2024). https://doi.org/10.1007/s11764-024-01552-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11764-024-01552-z